Trait markers for alcoholism: clinical utility.
- Authors
- Farren, C K; Tipton, K F
- Year
- 1999
- Journal
- Alcohol and alcoholism (Oxford, Oxfordshire)
- PMID
- 10528806
- DOI
- 10.1093/alcalc/34.5.649
Because alcoholism is a multi-factorial psychiatric disorder, with both psychosocial and biochemical/genetic factors leading to its manifestation in any one individual, the presence of biochemical/genetic factors alone may not lead to the manifestation of the disorder. There are numerous difficulties associated with identification of a trait abnormality in a disorder that requires suitable socio-cultural permissiveness with distinct behavioural characteristics to manifest a disorder that may not require that predisposing trait abnormality in order to develop. Numerous studies have been performed in the past to potentially identify a biochemical or genetic trait abnormality in alcoholism, and not all of them have addressed significant methodological flaws in this type of research. This review addresses some of the difficulties inherent in this research, and aims for a comprehensive review of the highlights of the search for a clinically useful trait abnormality. Some series of investigations hold promise that a trait marker for a particular subset of alcoholics may be developed, e.g. severe alcoholism and the dopamine D2 receptor gene; the level of reaction to alcoholism in family history-positive alcoholics; beta-endorphin abnormalities in specific family groups of alcoholics; reduced P3 wave event-related potentials as markers and predictors of development of substance abuse in predisposed youths; reduced growth hormone response to apomorphine as a predictor of relapse to alcoholism in early abstinence; abnormal adenylyl cyclase activity in certain defined subgroups of alcoholics; and abnormal platelet monoamine oxidase levels in subjects with a behavioural predisposition to addictive disorders. The review concludes that while there has not yet been an identification of a comprehensive trait marker for alcoholism, there is hope for identification subgroups of alcoholics with consistent biological markers within that subgroup that may well prove fruitful over time. It will then be up to a future generation of clinicians to take that information and develop prevention programmes that can incorporate this information to help the predisposed individual avoid alcohol problems.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Advances in Electrophysiological Research. | 2015 | 26259089 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Association between a MAOB Variable Number Tandem Repeat Polymorphism and Cocaine and Opiate Addictions in Polyconsumers. | Mateu C et al. | — | 2021 | → |
| Integrating Preclinical and Clinical Models of Negative Urgency. | Halcomb M et al. | — | 2019 | → |
| Why cognitive event-related potentials (ERPs) should have a role in the management of alcohol disorders. | Campanella S et al. | — | 2019 | → |
| Mercury Vapour Long-Lasting Exposure: Lymphocyte Muscarinic Receptors as Neurochemical Markers of Accidental Intoxication. | Roda E et al. | — | 2016 | → |
| Advances in Electrophysiological Research. | Kamarajan C et al. | — | 2015 | → |
| Effect of alcohol on blood glucose and antioxidant enzymes in the liver and kidney of diabetic rats. | Shanmugam KR et al. | — | 2011 | → |
| Chronic alcoholism: insights from neurophysiology. | Campanella S et al. | — | 2009 | → |
| Neuropsychological function and platelet monoamine oxidase activity levels in type I alcoholic patients. | Pombo S et al. | — | 2008 | → |
| Platelet monoamine oxidase kinetics, alcoholism subtypes and cigarette smoking. | Cicin-Sain L et al. | — | 2007 | → |
| Striatal dopamine release and family history of alcoholism. | Munro CA et al. | — | 2006 | → |
| Lymphocyte muscarinic receptors and platelet monoamine oxidase-B as biomarkers of CNS function: effects of age and gender in healthy humans. | Coccini T et al. | — | 2005 | → |
| The consumption of cigarettes, coffee and sweets in detoxified alcoholics and its association with relapse and a family history of alcoholism. | Junghanns K et al. | — | 2005 | → |
| Use of biomarkers for alcohol use disorders in clinical practice. | Neumann T et al. | — | 2003 | → |
| Biological markers of alcohol consumption in nondrinkers, drinkers, and alcohol-dependent Brazilian patients. | Figlie NB et al. | — | 2002 | → |
| Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction. | Naranjo CA et al. | — | 2002 | → |
| Alcoholism. | Schreiber A | — | 2001 | → |
| Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty. | Harro M et al. | — | 2001 | → |